Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.
about
Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@en
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@nl
type
label
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@en
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@nl
prefLabel
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@en
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@nl
P2093
P2860
P50
P356
P1476
Prolonged High-Dose Bivalirudi ...... From an Updated Meta-Analysis.
@en
P2093
Giovanni Luigi De Maria
Gregor Fahrni
Mathias Wolfrum
P2860
P356
10.1161/JAHA.116.003515
P577
2016-07-22T00:00:00Z